ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Expert Interviews
Growth Hormone Releasing Hormones and Peptides: Research History
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 88473" data-attributes="member: 3"><p>[media=youtube]YCKMbZ13RTA[/media]</p><p></p><p></p><p>Nelson Vergel, the founder of ExcelMale.com, ClinicOptimizers.com and DiscountedLabs.com, interviews Dr. Richard Walker about the history of research on GHRH and GHRPs.</p><p>Richard F. Walker, Ph.D., R.Ph is well known for having popularized Sermorelin, a growth hormone-releasing hormone. He received a BS in pharmacy from Rutgers University, an MS in biochemistry from New Mexico State University and a Ph.D. in physiology from Rutgers University. He completed an internship in neuroanatomy/electrophysiology at Emory University College of Medicine, and postdoctoral fellowships in neuroendocrinology and neuropharmacology at Duke University College of Medicine (Center for the Study of Aging and Human Development) and the University of California, Berkeley, respectively. Dr. Walker held tenured faculty positions at Clemson University (Department of Zoology) and the University of Kentucky, College of Medicine (Department of Anatomy and Molecular Biology/Sanders-Brown Research Center on Aging). He left academia for a brief hiatus in the pharmaceutical industry serving as Director of Toxicology at SmithKline Beecham Pharmaceutical Corp. At the same time, he was also a research professor in the Department of Pharmacology at the Medical College of Pennsylvania and later at the University of South Florida (USF) College of Medicine. In addition to his research duties at USF, Walker served as Director for Research Compliance and also Director of USF CARES (Clinical Alliance for Research, Education, and Service). He has been the recipient of many federal (NSF, NIH, DOD), state and local research grants and has published extensively towards understanding the cause of senescence and treating functional deficits associated with organismal aging. Walker is currently Editor-in-Chief of Clinical Interventions in Aging, a source of evidence-based information for practitioners of age-management medicine published by Dove Medical Press and author of the book, “Why We Age: Insight into the cause of growing old” He is partner in ProSoma LLC which manufactures and distributes anti-aging products, and he also heads a private consulting company offering regulatory and scientific services to physicians and other health-care professionals.</p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 88473, member: 3"] [media=youtube]YCKMbZ13RTA[/media] Nelson Vergel, the founder of ExcelMale.com, ClinicOptimizers.com and DiscountedLabs.com, interviews Dr. Richard Walker about the history of research on GHRH and GHRPs. Richard F. Walker, Ph.D., R.Ph is well known for having popularized Sermorelin, a growth hormone-releasing hormone. He received a BS in pharmacy from Rutgers University, an MS in biochemistry from New Mexico State University and a Ph.D. in physiology from Rutgers University. He completed an internship in neuroanatomy/electrophysiology at Emory University College of Medicine, and postdoctoral fellowships in neuroendocrinology and neuropharmacology at Duke University College of Medicine (Center for the Study of Aging and Human Development) and the University of California, Berkeley, respectively. Dr. Walker held tenured faculty positions at Clemson University (Department of Zoology) and the University of Kentucky, College of Medicine (Department of Anatomy and Molecular Biology/Sanders-Brown Research Center on Aging). He left academia for a brief hiatus in the pharmaceutical industry serving as Director of Toxicology at SmithKline Beecham Pharmaceutical Corp. At the same time, he was also a research professor in the Department of Pharmacology at the Medical College of Pennsylvania and later at the University of South Florida (USF) College of Medicine. In addition to his research duties at USF, Walker served as Director for Research Compliance and also Director of USF CARES (Clinical Alliance for Research, Education, and Service). He has been the recipient of many federal (NSF, NIH, DOD), state and local research grants and has published extensively towards understanding the cause of senescence and treating functional deficits associated with organismal aging. Walker is currently Editor-in-Chief of Clinical Interventions in Aging, a source of evidence-based information for practitioners of age-management medicine published by Dove Medical Press and author of the book, “Why We Age: Insight into the cause of growing old” He is partner in ProSoma LLC which manufactures and distributes anti-aging products, and he also heads a private consulting company offering regulatory and scientific services to physicians and other health-care professionals. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Expert Interviews
Growth Hormone Releasing Hormones and Peptides: Research History
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top